(S1 (S (S (PRN (-LRB- -LSB-) (NP (NP (NN Expression)) (PP (IN of) (NP (NN metastasis) (NN suppressor) (NN gene) (CD nm23))) (PP (IN in) (NP (JJ human) (JJ hepatocellular) (NN carcinoma)))) (-RRB- -RSB-))) (. .)))
(S1 (S (PP (PP (IN For) (NP (NP (DT the) (NN purpose)) (PP (IN of) (S (VP (VBG investigating) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (JJ metastatic) (NN potential)) (PP (IN of) (NP (DT the) (NN tumor)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN nm23-H1) (NN mRNA)))))))))))) (, ,) (CC and) (PP (IN for) (S (VP (VBG determing) (NP (NP (DT the) (NN location)) (PP (IN of) (NP (DT the) (JJ positive) (NNS sites))) (PP (IN in) (NP (DT the) (NNS cells)))))))) (, ,) (NP (NP (NN tumor) (NN metastasis) (NN suppressor) (NN gene) (NN nm23-H1)) (PP (IN in) (NP (NP (JJ human) (NN hepatocellular) (NN carcinoma)) (PRN (-LRB- -LRB-) (CC and) (NP (NP (DT the) (JJ nonneoplastic) (NN area)) (VP (VBG surrounding) (NP (DT the) (NN tumor)))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NP (ADJP (FW in) (FW situ)) (NN hybridization)) (VP (VBG using) (NP (JJ digoxiginin-labeled) (NN nm23-H1) (JJ antisense) (JJ complementary) (NN RNA) (NN probe))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ primary) (NNS results)) (VP (VBD indicated) (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP (JJ positive) (NNS results) (SBAR (IN of) (S (NP (ADJP (FW in) (FW situ)) (NN hybridization)) (VP (VBP are) (NP (NP (NP (NN presence)) (PP (IN of) (NP (NP (NNS granules)) (CC or) (NP (NNS masses)))) (PP (IN in) (NP (DT the) (NN cytoplasm)))) (: ;) (NP (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (DT the) (JJR less) (NN expression)) (PP (IN of) (NP (NP (NN nm23-H1) (NN mRNA)) (, ,) (NP (NP (DT the) (JJR higher) (JJ metastatic) (NN rate)) (PP (IN of) (NP (NP (DT the) (JJ human) (JJ hepatocellular) (NN carcinoma)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)))))))) (: ;) (NP (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NN expression))) (PP (IN of) (NP (NN nm23-H1) (NN mRNA) (NN dose))))))) (ADVP (RB not)) (VP (VBP correlate) (PP (IN with) (NP (NP (DT some) (JJ other) (NNS factors)) (PP (JJ such) (IN as) (NP (NP (NN tumor) (NN size)) (CC and) (NP (NP (DT the) (NN background)) (PP (IN of) (NP (JJ other) (NN liver) (NNS diseases)))))))))))) (. .)))
